Methylphenidate Hydrochloride Chewable Tablets — Class II drug recall D-0573-2022
Ongoing recall by RISING PHARMACEUTICALS, reported 2022-03-02, distributed nationwide. Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to
| Recall number | D-0573-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | RISING PHARMACEUTICALS, East Brunswick, NJ, United States |
| Recall initiated | 2022-02-07 |
| Classified | 2022-02-22 |
| Reported by FDA | 2022-03-02 |
| Distributed | Nationwide (US) |
| NDC | 64980-0221, 64980-0221-01, 64980-0222, 64980-0222-01, 64980-0223, 64980-0223-01 |
| Lot numbers | 25910009 |
| Expiration dates | 2023-01 |
Product
Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., Saddle Brook, NJ 07863, NDC 64980-221-01
Reason for recall
Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0573-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.